Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic
- PMID: 35316855
- PMCID: PMC9111650
- DOI: 10.1111/dar.13465
Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic
Abstract
Introduction: There were repeated reports of increased cannabis sales, use and health impacts in Canada during the COVID-19 pandemic. However, it was unclear whether the increases were due to pandemic effects or industry expansion.
Methods: We performed interrupted time series regressions of monthly per capita legal cannabis sales from March 2019 to February 2021, first with national averages, then with provincial/territorial data after adjusting for store density. We considered two interruption alternatives: January 2020, when product variety increased; and March 2020, when pandemic restrictions began.
Results: The provincial/territorial regression with the January interruption explained R2 = 69.6% of within-jurisdiction variation: baseline monthly per capita sales growth averaged $0.21 (95% confidence interval [CI] 0.15, 0.26), sales immediately dropped in January by $1.02 (95% CI -1.67, -0.37), and monthly growth thereafter increased by $0.16 (95% CI 0.06, 0.25). With the March interruption, the regression instead explained 68.7% of variation: baseline sales growth averaged $0.14 (95% CI 0.06, 0.22), there was no immediate drop and growth thereafter increased by $0.22 per month (95% CI 0.08, 0.35).
Discussion and conclusions: Increasing cannabis sales during the pandemic was consistent with pre-existing trends and increasing store numbers. The extra increased growth was more aligned with January's new product arrivals than with March's pandemic measures, though the latter cannot be ruled out. We found little evidence of pandemic impacts on Canada's aggregate legal cannabis sales. We therefore caution against attributing increased population-level cannabis use or health impacts primarily to the pandemic.
Keywords: COVID-19 pandemic; cannabis; health economics; interrupted time series analysis; legalisation.
© 2022 Australasian Professional Society on Alcohol and other Drugs.
Conflict of interest statement
The authors have all completed International Committee of Medical Journal Editors conflict of interest forms. The authors declare that they have no conflicts.
Figures
References
-
- Statistics Canada . Table 20‐10‐0008‐01, Retail trade sales by province and territory (x 1,000); 2021a. Available at: 10.25318/2010000801-eng (accessed March 2021). - DOI
-
- Fletcher R. Alberta walks back claim people are buying more alcohol and cannabis during pandemic. CBC News, 15 June 2020. Available at: https://www.cbc.ca/news/canada/calgary/alberta-health-liquor-cannabis-sa... (accessed June 2021).
-
- Saint‐Arnaud P. Quebec's cannabis profits nearly double in a year. Montreal Gazette. 2021. Available at: https://montrealgazette.com/cannabis/cannabis-business/quebecs-cannabis-... (accessed June 2021).
-
- Mental Health Commission of Canada . Mental Health and Substance Use During COVID‐19: Summary Report; 2021. Available at: https://www.mentalhealthcommission.ca/sites/default/files/2021-04/mhcc_c... (accessed July 2021).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
